Dr. Zidong Zhang 张子栋博士
Chief Financial Officer, Shanghai Henlius Biotech, Inc.
Zidong Zhang joined Henlius as Chief Financial Officer (CFO) from 2018. Zidong Zhang graduated from Fudan University for BS in chemistry, then obtained Ph.D. degree from Boston University in Biochemistry and MBA from Duke University the Fuqua School of Business. Prior to joining Henlius, Dr. Zhang worked as Equity Analyst for UBS in New York, covering US large Cap Pharmaceuticals and Specialty Pharmaceutical sector. He had a key focus in therapeutic areas as Oncology (especially for Immuno Oncology), autoimmune diseases, and other areas as Women’s health and CNS. He also developed a specialty and in-depth knowledge in generics market entry pathway and bio-similar entry/competition. Before UBS, he also worked for Bayer in the US as an internal consultant. He had multiple projects across US, Europe, and China, including strategic planning and market forecasts for US and China, merger and acquisition, organizational structure design and implementation etc.